Patient Guide: Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 64 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06107413
Status: 🟢 Enrolling Now
Condition: Unresectable Metastatic Colorectal Cancer
Phase: PHASE2

Where You Can Participate

This study is available at 64 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Springdale, Arkansas
  • • Duarte, California
  • • And 61 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and Bevacizumab - Join Clinical Trial NCTNCT06107413

How to Join This Clinical Trial - NCTNCT06107413

Learn how to participate in this PHASE2 trial studying an investigational therapy for Unresectable Metastatic Colorectal Cancer. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Unresectable Metastatic Colorectal Cancer. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Unresectable Metastatic Colorectal Cancer
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06107413 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 64 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85054 - United States

Status: RECRUITING

Clinical Research Site

Springdale, Arkansas 72762 - United States

Status: COMPLETED

Clinical Research Site

Duarte, California 91010 - United States

Status: RECRUITING

Clinical Research Site

Irvine, California 92618 - United States

Status: RECRUITING

Clinical Research Site

New Haven, Connecticut 06519 - United States

Status: RECRUITING

Clinical Research Site

Jacksonville, Florida 32224 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60607 - United States

Status: RECRUITING

Clinical Research Site

Chicago, Illinois 60611-2927 - United States

Status: RECRUITING

Clinical Research Site

Fort Wayne, Indiana 46804 - United States

Status: RECRUITING

Clinical Research Site

Indianapolis, Indiana 46202-5116 - United States

Status: RECRUITING

And 54 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Unresectable Metastatic Colorectal Cancer:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships